5 ms·

Walk around Google Geneva (edit: doh, Zurich - my coffee hasn't kicked in), Novartis Basel, or CERN and count how many "Swiss" nationals there are. A large port

Walk around Google Geneva (edit: doh, Zurich - my coffee hasn't kicked in), Novartis Basel, or CERN and count how many "Swiss" nationals there are. A large portion are white collar immigrants from CEE or Asia, or French commuters. Switzerland's comparative advantage as an innovation hub was due to it's permissive capital structures and historic openness to white collar immigration. All that a rule like this does is incentivize moving jobs out of Switzerland. Heck, look at UBS axing 3,000 jobs across all functions in CH and shifting them to India [0] last Wednesday. If UBS, Novartis, Google Geneva (edit: doh, Zurich - my coffee hasn't kicked in), etc cannot continue to attract employees they will leave, and given the extremely friendly FTAs and BITs Switzerland [1] has signed either unilaterally or part of the EFTA, it's extremely easy. Heck, look at how Syngenta went from being a Swiss major that employed thousands in Switzerland to a Chinese major that is about to IPO in Hong Kong [2] in just a decade. Already 1 out of every 3 Swiss businesses is planning to shift out of Switzerland (primarily to the EU and US, but Asia comes up as well) [3]. Switzerland doesn't have the same comparative advantage in finance 40 years ago (why Basel when I can go to London, Frankfurt, or Amsterdam) nor manufacturing (why CH and not DE or CN) and this kind of ruling puts it's entire life sciences industry - the last industry within which CH remains a global leader - in jeopardy. Additionally, Switzerland is not in the EU and is dependent on the EU-Switzerland FTA. If this were to pass, it would violate that FTA with Switzerland's largest trading partner. The EU can severely push back against CH, and France+Germany+Italy would very much support such retaliation as it would help incentivize Swiss businesses to shift out of Switzerland. [0] - https://www.reuters.com/business/finance/ubs-plans-hire-3000-new-roles-india-it-axes-jobs-switzerland-2026-02-11/ https://www.reuters.com/business/finance/ubs-plans-hire-3000... [1] - https://www.seco.admin.ch/seco/en/home/Aussenwirtschaftspolitik_Wirtschaftliche_Zusammenarbeit/Wirtschaftsbeziehungen/Freihandelsabkommen/partner_fha.html https://www.seco.admin.ch/seco/en/home/Aussenwirtschaftspoli... [2] - https://www.reuters.com/world/china/syngenta-targets-up-10-billion-hong-kong-listing-2026-sources-say-2026-02-05/ https://www.reuters.com/world/china/syngenta-targets-up-10-b... [3] - https://www.thelocal.ch/20251023/swiss-companies-set-to-relocate-thousands-of-jobs-abroad-bosses-fear https://www.thelocal.ch/20251023/swiss-companies-set-to-relo...

KellyCriterion 9mo ago
Swiss comp advantage started in WWII when they were used to exchange Nazis gold into other currencies - this gave them a topstart for the economic period after the war since they were perfectly connected globally and they understood to scale & keep this advantage for long time. Maybe its fading a little bit nowadays
- alephnerd 9mo ago
  Sure in finance (and even then it has been overshadowed by London, Frankfurt, and Amsterdam by the 2000s), but not really in innovation industries like the Life Sciences - which has historically been Switzerland's strongest niche and a major reason for Switzerland's modern success. This was largely due to the success of Biogen in the 1980s which helped link American biopharma IP with the Swiss ecosystem along with a fairly permissive PR program for skilled foreign nationals. Edit: cannot reply > Roche and Lanza Roche and Lanza would have remained CDMOs if it wasn't for Biogen bringing an entire generation of Harvard and MIT Biopharma researchers to Switzerland in the 1980s and helped build an ecosystem for therapeutics and biopharma R&D. Much of Roche's biopharma and therapeutics leadership and IP is derived from Biogen alumni.
  - fakedang 9mo ago
    Biogen? Seriously? Swiss pharma was driven by Roche and Lonza, which are much older than Biogen.
  - KellyCriterion 9mo ago
    Some say Swiss was always "naturally lucky" due its location in the "blue banana" region: https://en.wikipedia.org/wiki/Blue_Banana https://en.wikipedia.org/wiki/Blue_Banana
- spwa4 9mo ago
  To be honest during WWII, Switzerland was surrounded by the Nazis. Literally. On all sides, and learned a harsh lesson on not just the importance of military readiness but also economic resilience. So they took what they could get.

KellyCriterion 9mo ago

Swiss comp advantage started in WWII when they were used to exchange Nazis gold into other currencies - this gave them a topstart for the economic period after the war since they were perfectly connected globally and they understood to scale & keep this advantage for long time. Maybe its fading a little bit nowadays

alephnerd 9mo ago
Sure in finance (and even then it has been overshadowed by London, Frankfurt, and Amsterdam by the 2000s), but not really in innovation industries like the Life Sciences - which has historically been Switzerland's strongest niche and a major reason for Switzerland's modern success. This was largely due to the success of Biogen in the 1980s which helped link American biopharma IP with the Swiss ecosystem along with a fairly permissive PR program for skilled foreign nationals. Edit: cannot reply > Roche and Lanza Roche and Lanza would have remained CDMOs if it wasn't for Biogen bringing an entire generation of Harvard and MIT Biopharma researchers to Switzerland in the 1980s and helped build an ecosystem for therapeutics and biopharma R&D. Much of Roche's biopharma and therapeutics leadership and IP is derived from Biogen alumni.
- fakedang 9mo ago
  Biogen? Seriously? Swiss pharma was driven by Roche and Lonza, which are much older than Biogen.
- KellyCriterion 9mo ago
  Some say Swiss was always "naturally lucky" due its location in the "blue banana" region: https://en.wikipedia.org/wiki/Blue_Banana https://en.wikipedia.org/wiki/Blue_Banana
spwa4 9mo ago
To be honest during WWII, Switzerland was surrounded by the Nazis. Literally. On all sides, and learned a harsh lesson on not just the importance of military readiness but also economic resilience. So they took what they could get.